Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GLOBAL BREAST IMPLANT SETTLEMENT SCIENCE PANEL WILL PROVIDE OPINIONS INOPT-OUT CASES; FIRST CLAIMANT STATUS LETTERS ISSUED BY COURT ON MAY 31

This article was originally published in The Gray Sheet

Executive Summary

An expert panel to provide input on scientific issues in silicone breast implant litigation is being established under an order issued May 30 by U.S. District Court of Alabama Judge Samuel Pointer, the federal judge overseeing consolidated litigation against manufacturers of silicone gel breast implants. The panel will offer advice in cases being pursued by plaintiffs that opted out of the global breast implant settlement approved by Pointer in October 1995.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT006081

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel